HANSIZHUANG Sets Sail in Indonesia Market - Thailand Business News

SHANGHAI, Dec. 28, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announces that recently, PT Kalbio Global Medika, the subsidiary of Henlius'

Related Keywords

China ,Turkey ,United States ,Indonesia ,Georgia ,Thailand ,Shanghai ,United Kingdom ,Poland ,Chinese ,British ,American ,Indonesian ,Badan Pengawas Obat ,Kalbe Genexine Biologics Kgbio ,European Union ,Journal Of The American Medical Association ,Shanghai Henlius Biotech Inc ,European Commission ,Indonesia National Agency For Drug ,European Medicines Agency ,National Medicinal Products Administration ,Drug Administration ,Southeast Asia ,Shanghai Henlius Biotech ,Global Medika ,Genexine Biologics ,National Agency ,Food Control ,American Medical Association ,North African ,Nature Medicine ,British Journal ,Small Cell Lung Cancer ,Non Small Cell Lung Cancer ,Esophageal Cancer ,Colorectal Cancer ,Practice Guidelines ,Immune Checkpoint Inhibitor ,China Guidelines ,Cancer Statistics ,Combined Treatment Modality ,Small Cell Lung ,Strahlentherapie Und Onkologie ,Thailand Business ,